|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/12 | |
| C07D 401/14 | |||
| C07D 405/14 | |||
| C07D 413/14 | |||
| A61K 31/4439 | |||
| A61P 25/00 |
| (11) | Number of the document | 2590963 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11728862.1 |
| Date of filing the European patent application | 2011-07-04 | |
| (97) | Date of publication of the European application | 2013-05-15 |
| (45) | Date of publication and mention of the grant of the patent | 2014-12-03 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2011/061168 |
| Date | 2011-07-04 |
| (87) | Number | WO 2012/004207 |
| Date | 2012-01-12 |
| (30) | Number | Date | Country code |
| 10168688 | 2010-07-07 | EP |
| (72) |
NETTEKOVEN, Matthias, DE
RATNI, Hasane, FR
VIFIAN, Walter, CH
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | (3-METHYLPYRROLIDIN-3-YL)METHYL PYRIDINYL ETHER DERIVATIVES AND THEIR USE AS NK-3 RECEPTOR ANTAGONISTS |
| (3-METHYLPYRROLIDIN-3-YL)METHYL PYRIDINYL ETHER DERIVATIVES AND THEIR USE AS NK-3 RECEPTOR ANTAGONISTS |